SYH2069 Injection placebo

DRUG2 trials

Sponsors

CSPC Ouyi Pharmaceutical Co., Ltd.

Conditions

Overweight or ObesityT2DM (Type 2 Diabetes Mellitus)

Phase 2

A Study of SYH2069 Injection in Participants With T2DM Not Controlled With Diet/Exercise Alone or Metformin

Not yet recruitingNCT07796477

CSPC Ouyi Pharmaceutical Co., Ltd.T2DM (Type 2 Diabetes Mellitus)

Start: 2026-11-06End: 2027-10-19Target: 240Updated: 2026-09-01

Efficacy and Safety of SYH2069 Injection in Obese Participants Without Diabetes.

Not yet recruitingNCT07803991

CSPC Ouyi Pharmaceutical Co., Ltd.Overweight or Obesity

Start: 2026-09-01End: 2027-12-31Target: 360Updated: 2026-09-04